Stock Groups

Amgen Earnings Beat, Revenue Misses In Q4 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Amgen Earnings Beat, Revenue Misses In Q4

Amgen (NASDAQ 🙂 announced Monday that the fourth quarter beat analyst forecasts, and that revenue fell below expectations.

Amgen posted earnings per share (EPS) of $4.36 on $6.85B in revenue. Investing.com polled analysts and predicted an EPS of 4.07 for $6.88B in revenue.

Amgen shares have fallen 0% since the start of the year. However, they are still 14.30% below their 52-week high of $260.82 on April 21st 2021. The Nasdaq is also down by 10.41% since the beginning of the year.

Amgen shares gained 2.9% in trading after-hours due to the report.

Amgen and other healthcare sector leaders report this month

Amgen’s announcement follows a UnitedHealth earnings beat on January 19th, reporting EPS at $4.48 per share on revenues of $73.74B. Forecasts for EPS were $4.3 on revenues of $72.98B.

J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]